Novartis (NVS) Misses Q4 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Novartis (NVS) slides as Q4 EPS, revenue miss estimates
January 31, 2024 7:30 AM ESTNovartis (NYSE: NVS) stock fell 4% in premarket trading Wednesday after the Swiss pharmaceutical company reported worse-than-expected core earnings for the fourth quarter.
Concretely, Novartis posted Q4 core earnings per share (EPS) of $1.53, missing the consensus projection of $1.66. Revenue came in at $11.42 billion, also below the estimated... More

